CDKN2A and cancer: The normal and cancer groups presented significantly different expression levels of BRCA1, BRCA2, BRIP1, CDH1, CDKN2A, CHEK2, ERBB2, MSH2, PALB2, PTEN, and TP53 (Supplementary Fig. 6A).